Revenue Breakdown
Composition ()
No data
Revenue Streams
Profitability & Margins
Evaluating the bottom line, Kestra Medical Technologies Ltd maintains a gross margin of 50.63%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -140.73%, while the net margin is -145.29%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively KMTS converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, KMTS competes directly with industry leaders such as BWAY and NVCR. With a market capitalization of $1.49B, it holds a leading position in the sector. When comparing efficiency, KMTS's gross margin of 50.63% stands against BWAY's 75.19% and NVCR's 73.25%. Such benchmarking helps identify whether Kestra Medical Technologies Ltd is trading at a premium or discount relative to its financial performance.
